drugset / Trial / NCT01795937

Investigation of Interactions Between Faldaprevir, Itraconazole, Atorvastatin and Rosuvastatin

NCT01795937

Phase 1 Completed 51 enrolled Boehringer Ingelheim
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To investigate the effect of steady-state itraconazole on the pharmacokinetics of steady-state of faldaprevir and the effect of steady-state of faldaprevir on the single-dose pharmacokinetics of atorvastatin as well as the effect of steady-state of faldaprevir on the single-dose pharmacokinetics of rosuvastatin

Timeline

Start
2013-02
Primary completion
2013-03
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule
Subject Faldaprevir Small molecule
Subject Itraconazole Small molecule
Subject Rosuvastatin Small molecule

Indications

No indication recorded.